- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interferon-beta-1a (Avonex) plus methylprednisolone
Total 169 results
-
Johns Hopkins UniversityBiogenWithdrawn
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
BiogenRecruitingMultiple SclerosisSpain, Ireland, United States, Germany
-
Synairgen Research Ltd.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
BiogenCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
Saint Francis CareBiogenCompleted
-
Synairgen Research Ltd.Completed
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
EMD SeronoPfizerCompletedMultiple SclerosisUnited States
-
BiogenCompleted
-
EMD SeronoTerminatedMultiple SclerosisUnited States
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedHealthy Subjects | Pharmacokinetics | PharmacodynamicsUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Serono Middle East FZ LLCCompletedRelapsing Multiple Sclerosis (RMS)Bulgaria, Poland, Argentina, Hungary, Korea, Republic of, Saudi Arabia, Egypt, Algeria, Bahrain, Iran, Islamic Republic of, Kuwait, Lebanon, Morocco
-
Beth Israel Deaconess Medical CenterBiogenCompletedMultiple Sclerosis | Optic Neuritis | Transverse Myelitis | Acute Brainstem/Cerebellar SyndromeUnited States, Canada
-
AstraZenecaCompletedAsthmaFrance, United Kingdom, Korea, Republic of, Argentina, Australia, Spain, Colombia
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
CelgeneCompletedMultiple SclerosisUnited States, Spain, Czechia, Russian Federation, Portugal, Serbia, United Kingdom, New Zealand, Belarus, Bulgaria, Poland, Romania, Estonia, Germany, Sweden, Ukraine, Hungary, Croatia, Georgia, Bosnia and Herzegovina, Latvia, Li... and more
-
CelgeneCompletedRelapsing Multiple SclerosisSpain, United States, United Kingdom, Croatia, Serbia, Belarus, Hungary, Bulgaria, Poland, Italy, Ukraine, Greece, Belgium, Georgia, Bosnia and Herzegovina, Moldova, Republic of, Romania, Russian Federation, Slovakia, South Africa and more
-
University of California, San FranciscoOregon Health and Science University; National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Belgium, Czechia, Russian Federation, Serbia, Spain, Italy, Netherlands, Finland, Estonia, Brazil, France, Germany, Poland, Switzerland, Ukraine, Peru, Argentina, Lithuania, Slovakia, Portugal, Australia, Hungary, Tunisia, Bulgar... and more
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Spain, Czechia, Belgium, Italy, Canada, United Kingdom, Germany, Ireland, Turkey, Poland, Russian Federation, Ukraine, Croatia, Argentina, France, Belarus, Brazil, Mexico, Bosnia and Herzegovina, Bulgaria, Slovakia, S... and more
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Faron Pharmaceuticals LtdTerminatedPreventive Medicine | Multi Organ FailureLithuania, Estonia, Finland
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
EMD SeronoTerminatedCrohn's DiseaseGermany, Italy, Sweden, Switzerland, United Kingdom
-
BiogenCompleted
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
National Institute of Neurological Disorders and...Completed
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
BiogenCompletedHealthy VolunteersUnited States
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenCompleted
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
German University in CairoRecruiting
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
National Institute of Allergy and Infectious Diseases...Completed
-
BiocadCompletedHealthyRussian Federation
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
Qassim UniversityUnknown
-
BiogenCompletedMultiple SclerosisSweden, France, United Kingdom, Germany, Denmark, Netherlands, Slovakia, Switzerland, Norway, Portugal
-
Aaron BosterPfizer; EMD SeronoCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
Shahid Beheshti University of Medical SciencesUnknown